Nanobiosystems for Antimicrobial Drug-Resistant Infections
The worldwide increased bacterial resistance toward antimicrobial therapeutics has led investigators to search for new therapeutic options. Some of the options currently exploited to treat drug-resistant infections include drug-associated nanosystems. Additionally, the use of bacteriophages alone or...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Nanomaterials |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-4991/11/5/1075 |
id |
doaj-5e91c20afd544bd78a001185cad78e35 |
---|---|
record_format |
Article |
spelling |
doaj-5e91c20afd544bd78a001185cad78e352021-04-22T23:01:26ZengMDPI AGNanomaterials2079-49912021-04-01111075107510.3390/nano11051075Nanobiosystems for Antimicrobial Drug-Resistant InfectionsFoteini Gkartziou0Nikolaos Giormezis1Iris Spiliopoulou2Sophia G. Antimisiaris3Institute of Chemical Engineering, FORTH/ICES, Platani, 26504 Patras, GreeceNational Reference Centre for Staphylococci, School of Medicine, University of Patras, 26504 Patras, GreeceNational Reference Centre for Staphylococci, School of Medicine, University of Patras, 26504 Patras, GreeceInstitute of Chemical Engineering, FORTH/ICES, Platani, 26504 Patras, GreeceThe worldwide increased bacterial resistance toward antimicrobial therapeutics has led investigators to search for new therapeutic options. Some of the options currently exploited to treat drug-resistant infections include drug-associated nanosystems. Additionally, the use of bacteriophages alone or in combination with drugs has been recently revisited; some studies utilizing nanosystems for bacteriophage delivery have been already reported. In this review article, we focus on nine pathogens that are the leading antimicrobial drug-resistant organisms, causing difficult-to-treat infections. For each organism, the bacteriophages and nanosystems developed or used in the last 20 years as potential treatments of pathogen-related infections are discussed. Summarizing conclusions and future perspectives related with the potential of such nano-antimicrobials for the treatment of persistent infections are finally highlighted.https://www.mdpi.com/2079-4991/11/5/1075antimicrobial resistanceMRSAnanoparticleliposomesdrugbacteriophage |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Foteini Gkartziou Nikolaos Giormezis Iris Spiliopoulou Sophia G. Antimisiaris |
spellingShingle |
Foteini Gkartziou Nikolaos Giormezis Iris Spiliopoulou Sophia G. Antimisiaris Nanobiosystems for Antimicrobial Drug-Resistant Infections Nanomaterials antimicrobial resistance MRSA nanoparticle liposomes drug bacteriophage |
author_facet |
Foteini Gkartziou Nikolaos Giormezis Iris Spiliopoulou Sophia G. Antimisiaris |
author_sort |
Foteini Gkartziou |
title |
Nanobiosystems for Antimicrobial Drug-Resistant Infections |
title_short |
Nanobiosystems for Antimicrobial Drug-Resistant Infections |
title_full |
Nanobiosystems for Antimicrobial Drug-Resistant Infections |
title_fullStr |
Nanobiosystems for Antimicrobial Drug-Resistant Infections |
title_full_unstemmed |
Nanobiosystems for Antimicrobial Drug-Resistant Infections |
title_sort |
nanobiosystems for antimicrobial drug-resistant infections |
publisher |
MDPI AG |
series |
Nanomaterials |
issn |
2079-4991 |
publishDate |
2021-04-01 |
description |
The worldwide increased bacterial resistance toward antimicrobial therapeutics has led investigators to search for new therapeutic options. Some of the options currently exploited to treat drug-resistant infections include drug-associated nanosystems. Additionally, the use of bacteriophages alone or in combination with drugs has been recently revisited; some studies utilizing nanosystems for bacteriophage delivery have been already reported. In this review article, we focus on nine pathogens that are the leading antimicrobial drug-resistant organisms, causing difficult-to-treat infections. For each organism, the bacteriophages and nanosystems developed or used in the last 20 years as potential treatments of pathogen-related infections are discussed. Summarizing conclusions and future perspectives related with the potential of such nano-antimicrobials for the treatment of persistent infections are finally highlighted. |
topic |
antimicrobial resistance MRSA nanoparticle liposomes drug bacteriophage |
url |
https://www.mdpi.com/2079-4991/11/5/1075 |
work_keys_str_mv |
AT foteinigkartziou nanobiosystemsforantimicrobialdrugresistantinfections AT nikolaosgiormezis nanobiosystemsforantimicrobialdrugresistantinfections AT irisspiliopoulou nanobiosystemsforantimicrobialdrugresistantinfections AT sophiagantimisiaris nanobiosystemsforantimicrobialdrugresistantinfections |
_version_ |
1721513897948610560 |